• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

异基因造血干细胞移植后肝功能不全患者的蛋白C和前胶原III肽水平

Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantation.

作者信息

Pihusch M, Wegner H, Goehring P, Salat C, Pihusch V, Andreesen R, Kolb H-J, Holler E, Pihusch R

机构信息

Abteilung fuer Haematologie und Internistische Onkologie, Klinikum der Universitaet Regensburg, Regensburg, Germany.

出版信息

Bone Marrow Transplant. 2005 Oct;36(7):631-7. doi: 10.1038/sj.bmt.1705114.

DOI:10.1038/sj.bmt.1705114
PMID:16062176
Abstract

Veno-occlusive disease (VOD) is one of the most serious complications following hematopoietic stem cell transplantation (HSCT) and is associated with a high mortality. We conducted a large trial on the clinical significance of protein C (PC) and procollagen III peptide (PNPIII) levels, which have been described as possible diagnostic markers of VOD. In total, 350 patients undergoing allogeneic HSCT were included. PC and PNPIII levels were analyzed prior to conditioning and weekly until 8 weeks after the HSCT. Signs of VOD and other transplantation-related complications (graft-versus-host disease (GVHD), toxicity, microangiopathic hemolytic anemia, infection) were recorded weekly throughout the trial. Patients showed a significant drop of the PC levels in VOD (70.3 vs 96.3%, P<0.001) and with increasing severity of aGVHD. Steroids increased the PC levels (69.4% vs 109.4%, P<0.001). The highest PNPIII levels were registered in patients with VOD (mean 6.3 IU/ml). Patients with aGVHD showed an elevation of PNPIII, especially patients with hepatic aGVHD. PC levels during conditioning do not predict VOD (98.5 vs 76.5%, NS). Although PC and PNPIII may play a role in the pathogenesis of VOD they cannot discriminate between complications with jaundice and are only of limited help in the differential diagnosis of VOD.

摘要

静脉闭塞性疾病(VOD)是造血干细胞移植(HSCT)后最严重的并发症之一,且死亡率很高。我们针对蛋白C(PC)和Ⅲ型前胶原肽(PNPIII)水平的临床意义进行了一项大型试验,这两种物质已被描述为VOD可能的诊断标志物。总共纳入了350例接受异基因HSCT的患者。在预处理前以及直至HSCT后8周每周分析PC和PNPIII水平。在整个试验过程中每周记录VOD的体征以及其他与移植相关的并发症(移植物抗宿主病(GVHD)、毒性、微血管病性溶血性贫血、感染)。VOD患者的PC水平显著下降(70.3%对96.3%,P<0.001),且随着急性GVHD严重程度的增加而下降。类固醇使PC水平升高(69.4%对109.4%,P<0.001)。VOD患者的PNPIII水平最高(平均6.3 IU/ml)。急性GVHD患者的PNPIII升高,尤其是肝脏急性GVHD患者。预处理期间的PC水平不能预测VOD(98.5%对76.5%,无显著性差异)。尽管PC和PNPIII可能在VOD的发病机制中起作用,但它们无法区分伴有黄疸的并发症,在VOD的鉴别诊断中帮助有限。

相似文献

1
Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后肝功能不全患者的蛋白C和前胶原III肽水平
Bone Marrow Transplant. 2005 Oct;36(7):631-7. doi: 10.1038/sj.bmt.1705114.
2
Predictive markers for hepatic veno-occlusive disease after hematopoietic stem cell transplantation in adults: a prospective single center study.成人造血干细胞移植后肝静脉闭塞病的预测标志物:一项前瞻性单中心研究
Bone Marrow Transplant. 2000 Oct;26(8):881-6. doi: 10.1038/sj.bmt.1702624.
3
Marked reduction in the incidence of hepatic veno-occlusive disease after allogeneic hematopoietic stem cell transplantation with CD34(+) positive selection.采用CD34(+)阳性选择的异基因造血干细胞移植后肝静脉闭塞病发病率显著降低。
Bone Marrow Transplant. 2001 May;27(9):983-8. doi: 10.1038/sj.bmt.1703025.
4
Time-related changes in the incidence, severity, and clinical outcome of hepatic veno-occlusive disease in hematopoietic stem cell transplantation patients during the past 10 years.造血干细胞移植患者肝静脉闭塞病的发病率、严重程度及临床结局在过去10年中的时间相关变化。
Transplant Proc. 2005 Jun;37(5):2285-9. doi: 10.1016/j.transproceed.2005.03.025.
5
Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.白细胞介素-18和可溶性白细胞介素2受体对部分伊朗患者造血干细胞移植后急性移植物抗宿主病发生情况的影响
Transpl Immunol. 2006 Jan;15(3):223-7. doi: 10.1016/j.trim.2005.10.002. Epub 2005 Nov 28.
6
[Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].[肝活检在异基因造血干细胞移植后肝功能障碍管理中的应用]
Zhonghua Yi Xue Za Zhi. 2005 Nov 16;85(43):3062-6.
7
IL-6 and IL-8 levels in plasma during hematopoietic progenitor transplantation.造血祖细胞移植期间血浆中的白细胞介素-6和白细胞介素-8水平。
Haematologica. 1998 Dec;83(12):1082-7.
8
A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.造血干细胞移植后儿童肝静脉闭塞病发病率、危险因素及治疗的前瞻性研究。
Haematologica. 2005 Oct;90(10):1396-404.
9
Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive disease.
Eur J Med Res. 1996 Nov 25;1(12):571-4.
10
Increased levels of soluble interleukin-2 receptor in veno-occlusive disease of the liver after allogenic bone marrow transplantation.异基因骨髓移植后肝静脉闭塞病中可溶性白细胞介素-2受体水平升高。
Transplantation. 1995 Dec 15;60(11):1293-9.

引用本文的文献

1
Alterations of hemostatic parameters in the early development of allogeneic hematopoietic stem cell transplantation-related complications.同种异体造血干细胞移植相关并发症早期的止血参数改变。
Ann Hematol. 2011 Oct;90(10):1201-8. doi: 10.1007/s00277-011-1273-5. Epub 2011 Jun 15.
2
Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.使基于质谱的平台适用于临床蛋白质组学应用:毛细管电泳联用质谱范例。
Crit Rev Clin Lab Sci. 2009;46(3):129-52. doi: 10.1080/10408360902805261.